Stefan Schulz
#172,415
Most Influential Person Now
Cancer researcher
Stefan Schulz's AcademicInfluence.com Rankings
Stefan Schulzphilosophy Degrees
Philosophy
#10400
World Rank
#14252
Historical Rank
Logic
#7273
World Rank
#8983
Historical Rank
Stefan Schulzbiology Degrees
Biology
#14215
World Rank
#17913
Historical Rank
Molecular Biology
#2424
World Rank
#2461
Historical Rank
Download Badge
Philosophy Biology
Stefan Schulz's Degrees
- PhD Cancer Biology Stanford University
- Masters Molecular Biology University of California, Berkeley
- Bachelors Biochemistry University of California, Berkeley
Why Is Stefan Schulz Influential?
(Suggest an Edit or Addition)Stefan Schulz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance (2013) (645)
- The Conserved Bardet-Biedl Syndrome Proteins Assemble a Coat that Traffics Membrane Proteins to Cilia (2010) (571)
- CXCR4 Regulates Interneuron Migration in the Developing Neocortex (2003) (432)
- A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia (2002) (380)
- Selective targeting of somatostatin receptor 3 to neuronal cilia (1999) (366)
- Homo- and Heterodimerization of Somatostatin Receptor Subtypes (2001) (324)
- Heterodimerization of Somatostatin and Opioid Receptors Cross-modulates Phosphorylation, Internalization, and Desensitization* (2002) (273)
- Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness (2011) (273)
- Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor (2004) (258)
- Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. (1999) (243)
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors (2021) (212)
- Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies (2002) (209)
- Carboxyl-terminal Splicing of the Rat μ Opioid Receptor Modulates Agonist-mediated Internalization and Receptor Resensitization* (1998) (198)
- PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent (2011) (183)
- Morphine induces terminal μ‐opioid receptor desensitization by sustained phosphorylation of serine‐375 (2004) (182)
- Receptor Endocytosis Counteracts the Development of Opioid Tolerance (2005) (179)
- CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells. (2005) (179)
- Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. (2006) (178)
- Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects (2019) (177)
- Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists (2020) (174)
- Differential β-Arrestin Trafficking and Endosomal Sorting of Somatostatin Receptor Subtypes* (2004) (173)
- C-terminal Splice Variants of the Mouse μ-Opioid Receptor Differ in Morphine-induced Internalization and Receptor Resensitization* (2001) (171)
- Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. (2000) (169)
- Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. (2000) (169)
- Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. (2009) (161)
- Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization* (2003) (161)
- Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies (2000) (156)
- Direct Evidence for Biphasic cAMP Responsive Element-Binding Protein Phosphorylation during Long-Term Potentiation in the Rat Dentate Gyrus In Vivo (1999) (153)
- Agonist‐selective patterns of µ‐opioid receptor phosphorylation revealed by phosphosite‐specific antibodies (2011) (142)
- Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling (2020) (142)
- Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. (1992) (135)
- Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours (2011) (134)
- Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. (2003) (134)
- Regional and cellular localization of the CXCl12/SDF‐1 chemokine receptor CXCR7 in the developing and adult rat brain (2008) (132)
- International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature (2018) (130)
- Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. (2012) (127)
- Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co‐localization in pain‐modulatory brain regions (1996) (127)
- Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. (2009) (127)
- Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. (2008) (125)
- Pain control by CXCR2 ligands through Ca2+ ‐regulated release of opioid peptides from polymorphonuclear cells (2006) (122)
- Differentiation of Opioid Drug Effects by Hierarchical Multi-Site Phosphorylation (2013) (116)
- Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. (2012) (113)
- Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia (1998) (113)
- Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms (2015) (111)
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide. (2013) (111)
- Targeting multiple opioid receptors – improved analgesics with reduced side effects? (2018) (111)
- ADP-ribosylation Factor-dependent Phospholipase D2 Activation Is Required for Agonist-induced μ-Opioid Receptor Endocytosis* (2003) (110)
- Somatostatin Signaling in Neuronal Cilia Is Criticalfor Object Recognition Memory (2010) (107)
- Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry (2011) (105)
- Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain (2008) (103)
- Involvement of Mitogen‐Activated Protein Kinase in Agonist‐Induced Phosphorylation of the μ‐Opioid Receptor in HEK 293 Cells (2000) (100)
- Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine‐dependent rats in vivo (1998) (99)
- Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. (2008) (99)
- Distribution, Targeting, and Internalization of the sst4 Somatostatin Receptor in Rat Brain (2000) (98)
- Immunocytochemical Identification of VPAC1, VPAC2, and PAC1 Receptors in Normal and Neoplastic Human Tissues with Subtype-Specific Antibodies (2004) (94)
- Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions. (2000) (94)
- Immunofluorescent identification of endomorphin‐2‐containing nerve fibers and terminals in the rat brain and spinal cord (1998) (88)
- Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation. (2010) (88)
- Patterns of SDF‐1α and SDF‐1γ mRNAs, migration pathways, and phenotypes of CXCR4‐expressing neurons in the developing rat telencephalon (2007) (85)
- Deciphering µ‐opioid receptor phosphorylation and dephosphorylation in HEK293 cells (2012) (83)
- Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system (1997) (82)
- Neuronal types expressing μ‐ and δ‐opioid receptor mRNA in the rat hippocampal formation (2004) (81)
- Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. (2008) (81)
- Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization (2018) (81)
- Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues* (2012) (79)
- Tonic Activation of CXC Chemokine Receptor 4 in Immature Granule Cells Supports Neurogenesis in the Adult Dentate Gyrus (2008) (78)
- Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: a light and electron microscopical study using the tyramide signal amplification technique. (1997) (76)
- Phospholipase D2 modulates agonist‐induced µ‐opioid receptor desensitization and resensitization (2003) (75)
- Reassessment of sst5 Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4 (2011) (69)
- New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting (2008) (67)
- Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters. (2005) (66)
- Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2 (2008) (66)
- Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. (2010) (64)
- Novel insights in somatostatin receptor physiology. (2007) (63)
- Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy (2015) (63)
- Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice (2002) (63)
- Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor. (1999) (62)
- Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor. (2020) (62)
- Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. (2007) (62)
- Hierarchical Organization of Multi-Site Phosphorylation at the CXCR4 C Terminus (2013) (61)
- Intracellular trafficking of somatostatin receptors (2008) (59)
- DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. (2012) (56)
- Analgesic Tolerance to High-Efficacy Agonists But Not to Morphine Is Diminished in Phosphorylation-Deficient S375A μ-Opioid Receptor Knock-In Mice (2011) (55)
- Prenylated proteins and lymphocyte proliferation: Inhibition by d‐limonene and related monoterpenes (1994) (53)
- SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary. (2015) (53)
- Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. (2004) (53)
- Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor (2009) (50)
- Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. (2015) (49)
- Membrane Glycoprotein M6a Interacts with the μ-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling* (2007) (49)
- Arylsulfatase G, a Novel Lysosomal Sulfatase* (2008) (49)
- Different mechanisms of homologous and heterologous μ‐opioid receptor phosphorylation (2015) (48)
- Balance between somatostatin and D2 receptor expression drives TSH‐secreting adenoma response to somatostatin analogues and dopastatins (2012) (48)
- Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition (2009) (47)
- Heterologous regulation of agonist‐independent μ‐opioid receptor phosphorylation by protein kinase C (2014) (45)
- Somatostatin Receptor 2 Is Activated in Cortical Neurons and Contributes to Neurodegeneration after Focal Ischemia (2004) (45)
- Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications. (2011) (44)
- Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours (2008) (44)
- Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists. (2013) (43)
- Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy (2012) (43)
- Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain (2014) (43)
- Maternal immune activation epigenetically regulates hippocampal serotonin transporter levels (2016) (42)
- Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice (2001) (42)
- ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. (2019) (41)
- Somatostatin mediates nitric oxide production by activating sst2 receptors in the rat retina (2002) (40)
- Design, synthesis, and biological evaluation of somatostatin-based radiopeptides. (2006) (39)
- Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. (2011) (39)
- Differential Expression of Somatostatin Receptor Subtype 1–5 Proteins in Numerous Human Normal Tissues (2012) (38)
- Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord (1998) (37)
- Loss of Morphine Reward and Dependence in Mice Lacking G Protein–Coupled Receptor Kinase 5 (2014) (37)
- CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney (2012) (37)
- Substantial migration of SVZ cells to the cortex results in the generation of new neurons in the excitotoxically damaged immature rat brain (2008) (36)
- UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues (2011) (35)
- A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway (2011) (34)
- Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions (2009) (34)
- Immunohistochemical Determination of Somatostatin Receptor Subtypes 1, 2A, 3, 4, and 5 in Various Adrenal Tumors (2004) (33)
- Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain (1998) (33)
- Diurnal Oscillation of Amygdala Clock Gene Expression and Loss of Synchrony in a Mouse Model of Depression (2015) (33)
- Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease (2015) (33)
- Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor (2015) (33)
- Reassessment of sst3 Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5 (2012) (32)
- Design of a multiple slice interface chamber and application for resolving the temporal pattern of CREB phosphorylation in hippocampal long-term potentiation (1997) (32)
- Cell-Autonomous Regulation of Mu-Opioid Receptor Recycling by Substance P (2015) (32)
- Rapid Dephosphorylation of G Protein-coupled Receptors by Protein Phosphatase 1β Is Required for Termination of β-Arrestin-dependent Signaling* (2011) (32)
- Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice (2011) (32)
- Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms (2014) (32)
- Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies (2006) (32)
- Leptin‐Target Neurones of the Rat Hypothalamus Express Somatostatin Receptors (2003) (31)
- Mechanisms of somatostatin‐evoked responses in neurons of the rat lateral amygdala (2005) (31)
- Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists (2019) (31)
- Inhibition by compactin demonstrates a requirement of isoprenoid metabolism for long-term potentiation in rat hippocampal slices (1997) (30)
- Differential Expression of sst1, sst2A, and sst3 Somatostatin Receptor Proteins in Low‐Grade and High‐Grade Astrocytomas (2004) (30)
- CXCL14 is no direct modulator of CXCR4 (2014) (29)
- Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer? (2010) (29)
- Perillic acid inhibits Ras/MAP kinase-driven IL-2 production in human T lymphocytes. (1997) (28)
- Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. (2013) (28)
- High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event (2012) (27)
- Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor. (2011) (27)
- Inhibitory Role of the Somatostatin Receptor SST2 on the Intracrine-regulated Cell Proliferation Induced by the 210-Amino Acid Fibroblast Growth Factor-2 Isoform (2003) (26)
- Immunolocalization of Full-length NK1 Tachykinin Receptors in Human Tumors (2006) (25)
- Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors. (2010) (25)
- Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin (2016) (24)
- Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7 (2013) (24)
- Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics (2008) (23)
- Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes (2016) (23)
- Emerging Paradigms of G Protein-Coupled Receptor Dephosphorylation. (2017) (23)
- Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody. (2006) (23)
- Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas (2017) (22)
- Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay. (2016) (22)
- The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors (2019) (22)
- Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets (2017) (22)
- Derivatives of 1-beta-D-ribofuranosylbenzimidazole 3',5'-phosphate that mimic the actions of adenosine 3',5'-phosphate (cAMP) and guanosine 3',5'-phosphate (cGMP). (1992) (22)
- Expression of the proliferation marker Ki‐67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas (2012) (21)
- Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization. (2016) (21)
- PI3Kγ integrates cAMP and Akt signalling of the μ‐opioid receptor (2014) (20)
- Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies (2020) (20)
- Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies (2013) (20)
- Induction of Proenkephalin Gene Expression in Cultured Bovine Chromaffin Cells Is Dependent on Protein Synthesis of AP‐1 Proteins (1996) (19)
- Modulation of μ-opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase γ (2010) (19)
- Expression and Function of Somatostatin Receptors in Peripheral Nerve Sheath Tumors (2005) (19)
- Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin (2019) (18)
- The role of vascular CXCR4 expression in colorectal carcinoma (2009) (18)
- Immunofluorescent identification of neuropeptide B-containing nerve fibers and terminals in the rat hypothalamus (2007) (17)
- Neuropeptide S precursor knockout mice display memory and arousal deficits (2017) (17)
- Interaction of brain somatostatin receptors with the PDZ domains of PSD‐95 (2007) (17)
- The somatostatin SST2A receptor in the rat trigeminal ganglion (2003) (17)
- Regulation of Spinal Dynorphin 1-17 Release by Endogenous Pituitary Adenylyl Cyclase-Activating Polypeptide in the Male Rat: Relevance of Excitation via Disinhibition (2011) (16)
- Phosphoproteomic analysis of the mouse brain mu‐opioid (MOP) receptor (2015) (16)
- Delta-opioid receptor-immunoreactive neurons in the rat cranial sensory ganglia (2005) (16)
- Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes (2017) (16)
- VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235 (2015) (16)
- Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor (2014) (16)
- Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer (2018) (15)
- Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors. (2013) (14)
- A Transplantable Phosphorylation Probe for Direct Assessment of G Protein-Coupled Receptor Activation (2012) (14)
- Agonist-regulated Cleavage of the Extracellular Domain of Parathyroid Hormone Receptor Type 1* (2010) (13)
- Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis (2020) (13)
- Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking. (2016) (13)
- Real-time monitoring of somatostatin receptor-cAMP signaling in live pituitary. (2010) (13)
- Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract (2007) (12)
- Analysis of Somatostatin Receptor 2A Immunohistochemistry, RT-qPCR, and In Vivo PET/CT Data in Patients With Pancreatic Neuroendocrine Neoplasm (2015) (12)
- Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. (2021) (12)
- New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling (2021) (11)
- Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I–IV astrocytic brain tumors (2018) (11)
- Tyramide signal amplification in brain immunocytochemistry: adaptation to electron microscopy (1999) (11)
- Fine‐tuning somatostatin receptor signalling by agonist‐selective phosphorylation and dephosphorylation: IUPHAR Review 5 (2014) (11)
- Effect of Brn-3a deficiency on primary nociceptors in the trigeminal ganglion (2005) (10)
- Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues. (2005) (10)
- Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor (2022) (9)
- Immunocytochemical identification of low-affinity NTS2 neurotensin receptors in parietal cells of human gastric mucosa. (2006) (9)
- Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation. (2014) (9)
- Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody (2019) (9)
- Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours (2019) (9)
- Carboxyl-Terminal Receptor Domains Control the Differential Dephosphorylation of Somatostatin Receptors by Protein Phosphatase 1 Isoforms (2014) (9)
- Expression of the mu‐opioid receptor is induced in dentate gyrus granule cells after focal cerebrocortical ischaemia and stimulation of entorhinal afferents (2005) (8)
- Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (8)
- Analgesic treatment with buprenorphine should be adapted to the mouse strain (2020) (8)
- Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality (2021) (7)
- Somatostatin receptors type 2 and 5 expression and localization during human pituitary development. (2014) (7)
- Somatostatin receptor subtypes 1 and 4 redundantly regulate neprilysin, the major amyloid-beta degrading enzyme in brain (2020) (7)
- Selective phosphorylation of threonine residues defines GPR84–arrestin interactions of biased ligands (2022) (7)
- Detection of inhibition of HIV-1 protease activity by an enzyme-linked immunosorbent assay (ELISA). (1993) (6)
- Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist (2021) (6)
- Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies (2020) (6)
- Rapid assessment of G protein signaling of four opioid receptors using a real-time fluorescence-based membrane potential assay. (2020) (6)
- Expression changes of somatostatin receptor subtypes sst2A, sst2B, sst3 and sst4 after a cortical contusion trauma in rats (2002) (6)
- The effects of kratom on restraint-stress-induced analgesia and its mechanisms of action. (2017) (5)
- HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants (2020) (5)
- VPAC 2 receptor expression in human normal and neoplastic tissues : evaluation of the novel MAB SP 235 (2015) (5)
- SR-17018 Stimulates Atypical µ-Opioid Receptor Phosphorylation and Dephosphorylation (2021) (4)
- Does chloride channel accessory 3 have a role in arthritis pain? A study on murine antigen-induced arthritis (2014) (4)
- Agonist-dependent and -independent kappa opioid receptor phosphorylation showed distinct phosphorylation patterns and resulted in different cellular outcomes (2017) (4)
- Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody (2022) (4)
- A novel G protein‐biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein‐coupled receptor kinase (2020) (4)
- Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2 (2014) (3)
- Heteromerization of endogenous mu and delta opioid receptors tunes mu opioid receptor signaling and trafficking (2018) (3)
- Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells (2017) (3)
- Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8 (2015) (3)
- Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues (2021) (3)
- Effects of [des-Tyr-d-Phe3]beta-casomorphin (2–5) on cortical EEG power spectra in rats (1994) (2)
- Opioid receptors in GtoPdb v.2021.3 (2021) (2)
- Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics (2022) (2)
- Effects of [des-Tyr-D-Phe3]beta-casomorphin (2–5) on sleep pattern in rats (1991) (2)
- Immunohistochemical expression of somatostatin receptor subtypes in various normal human tissues (2005) (2)
- Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61 (2021) (2)
- How Carvedilol activates β2-adrenoceptors (2022) (2)
- Original Article Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors (2012) (2)
- Multisite phosphorylation is required for sustained interaction with GRKs and arrestins in mediating rapid mu-opioid receptor desensitization. (2019) (2)
- Somatostatin receptor expression in stromal tumors of the gastrointestinal tract (2005) (2)
- Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus (2022) (1)
- Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin (2016) (1)
- In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies (2023) (1)
- The microcephaly gene Donson is essential for progenitors of cortical glutamatergic and GABAergic neurons (2021) (1)
- Rapid Dephosphorylation of G Protein-coupled Receptors by Protein Phosphatase 1 (cid:1) Is Required for Termination of (cid:1) -Arrestin-dependent Signaling (2011) (1)
- Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies (2020) (1)
- Somatostatin receptor expression in thyroid carcinomas: implications for diagnostics and therapy (2004) (0)
- Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies (2022) (0)
- Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets (2017) (0)
- Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues (2023) (0)
- Abstract 92: Comparative expression analysis of somatostatin receptor subtypes in human neuroendocrine tumors using two sets of new monoclonal antibodies. (2013) (0)
- ON/OFF Ganglion Cells Express the Somatostatin Subtype 1 Receptor in the Mouse Retina (2004) (0)
- Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies (2022) (0)
- Somatostatin receptors and filamin: a developing story (2012) (0)
- Agonist-selective phosphorylation of the human sst3 somatostatin receptor determined by phosphosite-specific antibodies (2015) (0)
- Somatostatin receptor subtypes 15 in pituitary tumors of various etiologies: investigation by immunohistochemistry (2006) (0)
- SR17018 stimulates atypical µ-opioid receptor phosphorylation and dephosphorylation (2021) (0)
- Somatostatin-receptor PET/CT for in-vivo quantification of receptor density - Correlation with immunohistochemistry using novel monoclonal and polyclonal antibodies (2010) (0)
- ARTICLE—THE MANY FACETS OF OPIOID RECEPTOR PHOSPHORYLATION Role of Phosphorylation Sites in Desensitization of m-Opioid Receptor (2015) (0)
- Immunocytochemical identification of low-affinity NTS 2 neurotensin receptors in parietal cells of human gastric mucosa (2006) (0)
- Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2 (2013) (0)
- Different Intracellular Signaling Systems Involved in Opioid Tolerance/Dependence (2003) (0)
- Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin (2019) (0)
- SAT-305 Veldoreotide (COR005) Mechanisms of Action Studies: Comparison to Octreotide and Pasireotide (2020) (0)
- Physiology of somatostatin receptors (2007) (0)
- The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor. (2022) (0)
- G protein signalling of native somatostatin receptors 2 and 5 in pituitary cells using a fluorescence-based membrane potential assay (2015) (0)
- Differential Distribution of the μ-Opioid Receptor Isoforms rMOR1 and rMOR1B in Rat Caudate-Putamen (1995) (0)
- Differential effect of octreotide treatment on expression of sstr2a, 3 and 5 in somatotroph adenomas (2013) (0)
- Chronic morphine induces adaptations in opioid receptor signaling in a thalamo-cortico-striatal circuit that are projection-dependent, sex-specific and regulated by mu opioid receptor phosphorylation (2023) (0)
- Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
- CXCR4– a new antiangiogenic target in colorectal carcinoma? (2009) (0)
- Contents Vol. 96, 2012 (2012) (0)
- Development of a 5-HT7 receptor antibody for the rat: the good, the bad, and the ugly. (2023) (0)
- Immunohistochemical expression pattern of somatostatin receptor subtypes 1–5 in pituitary tumors of various etiologies (2006) (0)
- Imaging somatostatin activity in live pituitary (2012) (0)
- Distribution and regulation of micro-opioid receptors (1997) (0)
- Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics (2022) (0)
- ペリリン酸はヒトのTリンパ球においてRAS/MAPキナーゼ‐駆動性IL‐2生産を阻害する (1997) (0)
- Identification of a novel SSTR3 full agonist and its activity in non-functioning pituitary adenoma model (2022) (0)
- Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor (2021) (0)
- Molecular mechanism of drugs of abuse (2019) (0)
- A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening (2022) (0)
- Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61 (2022) (0)
- Molecular mechanism of drugs of abuse: Functional selectivity of µ-opioid receptor ligands (2011) (0)
- C 16 Development and Preclinical Evaluation of the New Pan-Somatostatin PET Imaging Probe 68 Ga-DOTA-SOM 230 ( SOMscan ® ) (2012) (0)
- Evaluation of somatostatin, CXCR4 chemokine and endothelin a receptor expression in a large series of paragangliomas (2016) (0)
- Normalization of cortisol levels in Cushing's disease after medical pretreatment before surgery: effects on somatostatin receptor subtype expression and in vitro response to somatostatin analogs. (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stefan Schulz?
Stefan Schulz is affiliated with the following schools:
